Literature DB >> 7010074

The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects.

R L Prince, R G Larkins, F P Alford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7010074     DOI： 10.1016/0026-0495(81)90155-4

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  8 in total

1.  Acetylsalicylic acid and glucose metabolism in man: is there a role for prostaglandins?

Authors:  D Giugliano
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

Review 2.  Inflammation and insulin resistance.

Authors:  Steven E Shoelson; Jongsoon Lee; Allison B Goldfine
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

3.  Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man.

Authors:  P R Bratusch-Marrain; H Vierhapper; M Komjati; W K Waldhäusl
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

4.  The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.

Authors:  J Koska; E Ortega; J C Bunt; A Gasser; J Impson; R L Hanson; J Forbes; B de Courten; J Krakoff
Journal:  Diabetologia       Date:  2008-12-23       Impact factor: 10.122

Review 5.  A meta-analysis of salicylates for type 2 diabetes mellitus.

Authors:  Fang Fang; Yu Lu; De-Lin Ma; Ting-Ting Du; Shi-Ying Shao; Xue-Feng Yu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

Review 6.  Phenolic Compounds Impact on Rheumatoid Arthritis, Inflammatory Bowel Disease and Microbiota Modulation.

Authors:  Rosa Direito; João Rocha; Bruno Sepodes; Maria Eduardo-Figueira
Journal:  Pharmaceutics       Date:  2021-01-22       Impact factor: 6.321

7.  A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.

Authors:  Aruna D Pradhan; Nancy R Cook; Joann E Manson; Paul M Ridker; Julie E Buring
Journal:  Diabetes Care       Date:  2008-10-03       Impact factor: 19.112

8.  CXCL2 Impairs Functions of Bone Marrow Mesenchymal Stem Cells and Can Serve as a Serum Marker in High-Fat Diet-Fed Rats.

Authors:  Jianhai Bi; Qiuchen Li; Zhigang Yang; Lei Cai; Tao Lv; Xun Yang; Li Yan; Xia Liu; Qian Wang; Xin Fu; Ran Xiao
Journal:  Front Cell Dev Biol       Date:  2021-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.